Will France's tighter medtech reimbursement rules leave industry room to manoeuvre?
This article was originally published in Clinica
Executive Summary
France is using its reimbursement system to introduce more onerous requirements than for CE marking. In the second article in Clinica's series on EU reimbursement and HTA, Dr Mark Charny, managing director of UK-based consultancy Translucency, analyses the impact of the latest challenges to having products reimbursed under increasingly stringent French rules